Beth C Seidenberg
Director; Director, 10% Owner · 4 filings · Latest: Aug 10, 2026
Kyverna Therapeutics, Inc.
Latigo Biotherapeutics, Inc.
Sagimet Biosciences Inc.
Vera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PGNY | SEIDENBERG BETH C | — | Dec 9, 2024 | Proposed Sale | $15.82 | 39,680 | $627.6K | — | |
VERA | BETH C SEIDENBERG | — | Oct 28, 2024 | Proposed Sale | $41.09 | 15,000 | $616.4K | — | |
VERA | BETH C SEIDENBERG | — | Sep 18, 2024 | Proposed Sale | $40.02 | 15,000 | $600.3K | — | |
VERA | SAMUEL B SEIDENBERG IRREV TRUST U/A DTD 07/01/2013 | — | Sep 18, 2024 | Proposed Sale | $40.02 | 1,476 | $59.1K | — |